Recently, Post et al. [50,52] report a radio-labeled conjugate of DUPA and 99mTc derivative for selecting patients suitable for PSMA-targeted therapy and diagnosing PCa progress or recurrence. Here, FOLH1 is linked to posterior cortical atrophy.